• Login
Wednesday, November 18, 2026
Geneva Times
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil
No Result
View All Result
Geneva Times
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
Home Business

GSK wins approval for second lung cancer drug from $10.6bn Nuvalent deal

GenevaTimes by GenevaTimes
November 17, 2026
in Business
Reading Time: 1 min read
0
Share on FacebookShare on Twitter



FTSE 100 group secures US clearance for treatment of tumours that have advanced or proved resistant to previous therapies

Read More

Previous Post

Russian military plane crashes in Siberia killing all 19 on board

Next Post

Repsol’s net debt falls 64% to €2.04 billion as cash flow rises

Next Post
Repsol’s net debt falls 64% to €2.04 billion as cash flow rises

Repsol’s net debt falls 64% to €2.04 billion as cash flow rises

ADVERTISEMENT
Facebook Twitter Instagram Youtube LinkedIn

Explore the Geneva Times

  • About us
  • Contact us

Contact us:

editor@thegenevatimes.ch

Visit us

© 2023 -2026 Geneva Times| Desgined & Developed by Immanuel Kolwin

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil

© 2023 -2026 Geneva Times| Desgined & Developed by Immanuel Kolwin